Pfizer Inc. buy Guggenheim
Start price
18.03.25
/
50%
€24.09
Target price
18.03.26
-
Performance (%)
-11.91%
Price
17:12
€21.22
Summary
This prediction is currently active. The prediction for Pfizer Inc. disappoints with a performance of -11.91%. This prediction currently runs until 18.03.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | -0.819% | -0.819% |
| iShares Core DAX® | 2.339% | -0.341% |
| iShares Nasdaq 100 | 2.017% | 2.510% |
| iShares Nikkei 225® | 4.496% | 3.027% |
| iShares S&P 500 | 1.174% | 1.353% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for PFE provided by MarketBeat